#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heavy menstrual bleeding Anal cancer Congenital pseudarthrosis Glomerulonephritis acute Osteosarcoma metastatic Transient ischaemic attack Adenocarcinoma pancreas Follicular lymphoma Thrombotic thrombocytopenic purpura Subdural haematoma Keratosis follicular Malignant glioma Pustular psoriasis Muscular dystrophy Central nervous system neoplasm More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Diagnostics Ewing’s sarcoma – Basic Information Marginal zone lymphoma refractory Proteus syndrome – Diagnostics Gastrointestinal stromal tumour – Diagnostics VEXAS syndrome – Basic Information Pemphigus – Trials in Disease Cystic fibrosis – Basic Information Niemann-Pick disease – Diagnostics Von Willebrand’s disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Odevixibat Progesterone Resmetirom Gremubamab HLX43 Hydroxi-Methionine Calcium Vimseltinib Sufentanil Citrate Rituximab Urapidil Trifluridine Isis 678354 Sodium Salt Oregovomab [Al[18F]F]Fapi-74 Elotuzumab Kk8123 Namilumab Bemarituzumab Thiamine Nms-03592088 More therapies…

    Learn about Your Condition

    Dyslipidaemia Angiosarcoma non-metastatic Alcohol use disorder Wheezing Cardiomyopathy Hypertonic bladder Tissue anoxia Hypotransferrinaemia Mucous membrane pemphigoid Uterine leiomyosarcoma Otitis media Deafness Neonatal anoxia Diminished ovarian reserve Chondrosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety of Using Chemoradiation with Cisplatin and Carboplatin for Early-Stage Vulvar Cancer Patients with Macrometastasis in Sentinel Lymph Node

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Vulval cancer
    Investigated Drugs:
    • Cisplatin
    • Carboplatin
    Belgium France The Netherlands Sweden

  • Study on Pembrolizumab with Chemotherapy for Early-Stage Triple-Negative Breast Cancer in Patients with High TILs

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Glatiramer Acetate
    • Filgrastim
    Portugal

  • Study of Cytarabine, Daunorubicin, and Clofarabine for Children with Relapsed or Refractory Acute Myeloid Leukemia (AML)

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Clofarabine
    • Daunorubicin
    • Cytarabine
    Austria Denmark Germany Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Abatacept and Daratumumab for Patients with Rheumatoid Arthritis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    • Daratumumab
    Germany

  • Study on Iron and Mannitol for Anemia Recovery in Patients After Major Surgery with Blood Loss

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaemia
    Investigated Drugs:
    • Mannitol
    Sweden

  • Study on the Safety of RP-6306 Alone or with RP-3500 or Debio 0123 for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • 3-(2,6-Dichlorophenyl)-2,3-Dihydro-1-Methyl-7-[[3-Methyl-4-(1-Methyl-4-Piperidinyl)Phenyl]Amino]-Pyrimido[4,5-D]Pyrimidin-4(1H)-One
    • Camonsertib
    • LUNRESERTIB
    Denmark France The Netherlands Spain
Previous Page
1 … 447 448 449 450 451 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!